112 related articles for article (PubMed ID: 30509369)
1. Stem cells transplantation positively modulates the heart-kidney cross talk in cardiorenal syndrome type II.
Vescovo G; Castellani C; Fedrigo M; Virzì GM; Vescovo GM; Tavano R; Pozzobon M; Angelini A
Int J Cardiol; 2019 Jan; 275():136-144. PubMed ID: 30509369
[TBL] [Abstract][Full Text] [Related]
2. Stem-cell therapy in an experimental model of pulmonary hypertension and right heart failure: role of paracrine and neurohormonal milieu in the remodeling process.
Angelini A; Castellani C; Ravara B; Franzin C; Pozzobon M; Tavano R; Libera LD; Papini E; Vettor R; De Coppi P; Thiene G; Vescovo G
J Heart Lung Transplant; 2011 Nov; 30(11):1281-93. PubMed ID: 21989772
[TBL] [Abstract][Full Text] [Related]
3. The contribution of stem cell therapy to skeletal muscle remodeling in heart failure.
Castellani C; Vescovo G; Ravara B; Franzin C; Pozzobon M; Tavano R; Gorza L; Papini E; Vettor R; De Coppi P; Thiene G; Angelini A
Int J Cardiol; 2013 Oct; 168(3):2014-21. PubMed ID: 23453873
[TBL] [Abstract][Full Text] [Related]
4. Data on the stem cells paracrine effects on apoptosis and cytokine milieu in an experimental model of cardiorenal syndrome type II.
Vescovo G; Castellani C; Fedrigo M; Virzì GM; Vescovo GM; Tavano R; Pozzobon M; Angelini A
Data Brief; 2018 Dec; 21():1430-1434. PubMed ID: 30456267
[TBL] [Abstract][Full Text] [Related]
5. Subtotal nephrectomy accelerates pathological cardiac remodeling post-myocardial infarction: implications for cardiorenal syndrome.
Liu S; Kompa AR; Kumfu S; Nishijima F; Kelly DJ; Krum H; Wang BH
Int J Cardiol; 2013 Oct; 168(3):1866-80. PubMed ID: 23347614
[TBL] [Abstract][Full Text] [Related]
6. The Role of Congestion in Cardiorenal Syndrome Type 2: New Pathophysiological Insights into an Experimental Model of Heart Failure.
Angelini A; Castellani C; Virzì GM; Fedrigo M; Thiene G; Valente M; Ronco C; Vescovo G
Cardiorenal Med; 2015 Dec; 6(1):61-72. PubMed ID: 27194997
[TBL] [Abstract][Full Text] [Related]
7. Human amniotic fluid stem cell preconditioning improves their regenerative potential.
Rota C; Imberti B; Pozzobon M; Piccoli M; De Coppi P; Atala A; Gagliardini E; Xinaris C; Benedetti V; Fabricio AS; Squarcina E; Abbate M; Benigni A; Remuzzi G; Morigi M
Stem Cells Dev; 2012 Jul; 21(11):1911-23. PubMed ID: 22066606
[TBL] [Abstract][Full Text] [Related]
8. Adipose-derived stem cell and their extracellular vesicles ameliorates immune function, and cardiac markers in experimental model of cardiorenal syndrome type III: TNF-α, IFN-γ and IL-10 cytokine production and their correlation with genotype.
Alasmari WA; Faruk E; Fouad H; Radi R; El-Wafaey DI
Transpl Immunol; 2022 Jun; 72():101586. PubMed ID: 35364243
[TBL] [Abstract][Full Text] [Related]
9. Apocynin Attenuates Cardiac Injury in Type 4 Cardiorenal Syndrome via Suppressing Cardiac Fibroblast Growth Factor-2 With Oxidative Stress Inhibition.
Liu Y; Liu Y; Liu X; Chen J; Zhang K; Huang F; Wang JF; Tang W; Huang H
J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26109504
[TBL] [Abstract][Full Text] [Related]
10. Reactivating endogenous mechanisms of cardiac regeneration via paracrine boosting using the human amniotic fluid stem cell secretome.
Balbi C; Lodder K; Costa A; Moimas S; Moccia F; van Herwaarden T; Rosti V; Campagnoli F; Palmeri A; De Biasio P; Santini F; Giacca M; Goumans MJ; Barile L; Smits AM; Bollini S
Int J Cardiol; 2019 Jul; 287():87-95. PubMed ID: 30987834
[TBL] [Abstract][Full Text] [Related]
11. Role of inflammation in the pathogenesis of cardiorenal syndrome in a rat myocardial infarction model.
Cho E; Kim M; Ko YS; Lee HY; Song M; Kim MG; Kim HK; Cho WY; Jo SK
Nephrol Dial Transplant; 2013 Nov; 28(11):2766-78. PubMed ID: 24009291
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of naringenin in cardiorenal syndrome.
Liu Y; An W; Gao A
J Surg Res; 2016 Jun; 203(2):416-23. PubMed ID: 27363651
[TBL] [Abstract][Full Text] [Related]
13. Qiliqiangxin Protects against Renal Injury in Rat with Cardiorenal Syndrome Type I through Regulating the Inflammatory and Oxidative Stress Signaling.
Duan X; Yan F; Hu H; Liu H; Wu Q; Sun S; Ming X; Bu X; He Y; Zhu H
Biol Pharm Bull; 2018; 41(8):1178-1185. PubMed ID: 30068867
[TBL] [Abstract][Full Text] [Related]
14. Target organ cross talk in cardiorenal syndrome: animal models.
Bongartz LG; Braam B; Gaillard CA; Cramer MJ; Goldschmeding R; Verhaar MC; Doevendans PA; Joles JA
Am J Physiol Renal Physiol; 2012 Nov; 303(9):F1253-63. PubMed ID: 22914779
[TBL] [Abstract][Full Text] [Related]
15. Adipose-derived stem cells attenuate pulmonary arterial hypertension and ameliorate pulmonary arterial remodeling in monocrotaline-induced pulmonary hypertensive rats.
Luo L; Lin T; Zheng S; Xie Z; Chen M; Lian G; Xu C; Wang H; Xie L
Clin Exp Hypertens; 2015; 37(3):241-8. PubMed ID: 25271670
[TBL] [Abstract][Full Text] [Related]
16. Amniotic fluid stem cells are cardioprotective following acute myocardial infarction.
Bollini S; Cheung KK; Riegler J; Dong X; Smart N; Ghionzoli M; Loukogeorgakis SP; Maghsoudlou P; Dubé KN; Riley PR; Lythgoe MF; De Coppi P
Stem Cells Dev; 2011 Nov; 20(11):1985-94. PubMed ID: 21534857
[TBL] [Abstract][Full Text] [Related]
17. Increased susceptibility to structural acute kidney injury in a mouse model of presymptomatic cardiomyopathy.
Pleasant L; Ma Q; Devarajan M; Parameswaran P; Drake K; Siroky B; Shay-Winkler K; Robbins J; Devarajan P
Am J Physiol Renal Physiol; 2017 Sep; 313(3):F699-F705. PubMed ID: 28679593
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of allogenic and xenogeneic mesenchymal stem cells on cisplatin-induced acute kidney injury in Sprague-Dawley rats.
Ashour RH; Saad MA; Sobh MA; Al-Husseiny F; Abouelkheir M; Awad A; Elghannam D; Abdel-Ghaffar H; Sobh M
Stem Cell Res Ther; 2016 Sep; 7(1):126. PubMed ID: 27585525
[TBL] [Abstract][Full Text] [Related]
19. Distinct Endothelial Cell Responses in the Heart and Kidney Microvasculature Characterize the Progression of Heart Failure With Preserved Ejection Fraction in the Obese ZSF1 Rat With Cardiorenal Metabolic Syndrome.
van Dijk CG; Oosterhuis NR; Xu YJ; Brandt M; Paulus WJ; van Heerebeek L; Duncker DJ; Verhaar MC; Fontoura D; Lourenço AP; Leite-Moreira AF; Falcão-Pires I; Joles JA; Cheng C
Circ Heart Fail; 2016 Apr; 9(4):e002760. PubMed ID: 27056881
[TBL] [Abstract][Full Text] [Related]
20. The cardioprotective effect of melatonin and exendin-4 treatment in a rat model of cardiorenal syndrome.
Chua S; Lee FY; Chiang HJ; Chen KH; Lu HI; Chen YT; Yang CC; Lin KC; Chen YL; Kao GS; Chen CH; Chang HW; Yip HK
J Pineal Res; 2016 Nov; 61(4):438-456. PubMed ID: 27465663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
